{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:32:22Z","timestamp":1764858742914},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:00:00Z","timestamp":1395532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00280-014-2452-6","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T15:50:21Z","timestamp":1395503421000},"page":"1173-1179","source":"Crossref","is-referenced-by-count":8,"title":["Phase I and pharmacokinetic study of polymeric micelle-formulated paclitaxel in adult Chinese patients with advanced solid tumors"],"prefix":"10.1007","volume":"73","author":[{"given":"Fangfang","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junning","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,23]]},"reference":[{"key":"2452_CR1","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(00)02074-2","volume":"355","author":"J Crown","year":"2000","unstructured":"Crown J, O\u2019Leary M (2000) The taxanes: an update. Lancet 355:1176\u20131178","journal-title":"Lancet"},{"key":"2452_CR2","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","volume":"37","author":"H Gelderblom","year":"2001","unstructured":"Gelderblom H, Verweij J, Nooter K, Sparreboom A (2001) Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590\u20131598","journal-title":"Eur J Cancer"},{"key":"2452_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002800000215","volume":"47","author":"L Zuylen van","year":"2001","unstructured":"van Zuylen L, Karlsson MO, Verweij J, Brouwer E, de Bruijn P, Nooter K, Stoter G, Sparreboom A (2001) Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles. Cancer Chemother Pharmacol 47:309\u2013318","journal-title":"Cancer Chemother Pharmacol"},{"key":"2452_CR4","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1200\/JCO.2001.19.20.4065","volume":"19","author":"A Henningsson","year":"2001","unstructured":"Henningsson A, Karlsson MO, Vigano L, Gianni L, Verweij J, Sparreboom A (2001) Mechanism-based pharmacokinetic model for paclitaxel. J Clin Oncol 19:4065\u20134073","journal-title":"J Clin Oncol"},{"key":"2452_CR5","first-page":"1520","volume":"48","author":"WN Waugh","year":"1991","unstructured":"Waugh WN, Trissel LA, Stella VJ (1991) Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am J Hosp Pharm 48:1520\u20131524","journal-title":"Am J Hosp Pharm"},{"key":"2452_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1010682916808","volume":"19","author":"B Nuijen","year":"2001","unstructured":"Nuijen B, Bouma M, Schellens JH, Beijnen JH (2001) Progress in the development of alternative pharmaceutical formulations of taxanes. Investig New Drugs 19:143\u2013153","journal-title":"Investig New Drugs"},{"key":"2452_CR7","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","volume":"23","author":"WJ Gradishar","year":"2005","unstructured":"Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O\u2019Shaughnessy J (2005) Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil based paclitaxel in women with breast cancer. J Clin Oncol 23:7794\u20137803","journal-title":"J Clin Oncol"},{"key":"2452_CR8","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.2011.39.5848","volume":"30","author":"MA Socinski","year":"2012","unstructured":"Socinski MA, Bondarenko I, Karaseva NA, Makhson AM, Vynnychenko I, Okamoto I, Hon JK, Hirsh V, Bhar P, Zhang H, Iglesias JL, Renschler MF (2012) Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. J Clin Oncol 30:2055\u20132062","journal-title":"J Clin Oncol"},{"key":"2452_CR9","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s11095-010-0233-4","volume":"27","author":"C Oerlemans","year":"2010","unstructured":"Oerlemans C, Bult W, Bos M, Storm G, Nijsen JF, Hennink WE (2010) Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res 27:2569\u20132589","journal-title":"Pharm Res"},{"key":"2452_CR10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-007-9591-y","volume":"108","author":"KS Lee","year":"2008","unstructured":"Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim SB, Rha SY, Lee MY, Ro J (2008) Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat 108:241\u2013250","journal-title":"Breast Cancer Res Treat"},{"key":"2452_CR11","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","volume":"18","author":"DW Kim","year":"2007","unstructured":"Kim DW, Kim SY, Kim HK, Kim SW, Shin SW, Kim JS, Park K, Lee MY, Heo DS (2007) Multicenter phase II trial of Genexol-PM, a novel Cremophor free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol 18:2009\u20132014","journal-title":"Ann Oncol"},{"key":"2452_CR12","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/1078-0432.CCR-03-0655","volume":"10","author":"TY Kim","year":"2004","unstructured":"Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Bang YJ (2004) Phase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 10:3708\u20133716","journal-title":"Clin Cancer Res"},{"key":"2452_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.1995.13.1.180","volume":"13","author":"L Gianni","year":"1995","unstructured":"Gianni L, Kearns CM, Giani A, Capri G, Vigan\u00f3 L, Lacatelli A, Bonadonna G, Egorin MJ (1995) Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic\/pharmacodynamics relationships in humans. J Clin Oncol 13:180\u2013190","journal-title":"J Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2452-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2452-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T20:30:48Z","timestamp":1565296248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2452-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,23]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2452"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2452-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,23]]}}}